Moneycontrol
Get App
you are here: HomeNewsBusiness
Last Updated : Feb 11, 2020 12:59 PM IST | Source: PTI

Marksans Pharma gets EIR from USFDA for New York unit

In a regulatory filing, the company announced "receipt of the EIR from US Food and Drug Administration (USFDA) in respect of inspection of company's manufacturing facility Time-Cap Laboratories Inc. located at Farmingdale, New York, USA carried out from December 5, 2019 to December 18, 2019".

Representative image
Representative image
 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Marksans Pharma on Tuesday said it has received an establishment inspection report (EIR) from the US health regulator for company's manufacturing facility in the US.

In a regulatory filing, the company announced "receipt of the EIR from US Food and Drug Administration (USFDA) in respect of inspection of company's manufacturing facility Time-Cap Laboratories Inc. located at Farmingdale, New York, USA carried out from December 5, 2019 to December 18, 2019".

The shares of the company were trading at Rs 23.20 apiece on BSE, up 4.98 per cent from the previous close.

Exclusive offer: Use code "BUDGET2020" and get Moneycontrol Pro's Subscription for as little as Rs 333/- for the first year.

First Published on Feb 11, 2020 12:52 pm
Sections
Follow us on